Mounjaro vs Ozempic?

Hong Kong Yanpep International
The 'more mental less physical' framing between sema and tirz is a really useful shorthand. Sema tends to be more aggressive on the GI side and tirz tends to produce a cleaner appetite quieting without as much nausea. Starting in 2006 with GLP-1 receptor agonists is a long runway - curious what doses you were on in the earlier generation compounds compared to what's available now.
 
Having run both, the tirzepatide advantage is pretty clear - the dual GIP/GLP-1 mechanism genuinely does more than semaglutide alone for most people. The trial data backs that up, not just anecdote. Side effect profiles differ for everyone but on efficacy Mounjaro tends to pull ahead.
 
The 2.4mg ceiling on Ozempic before people feel it is real and the OP asking this is probably in that range. Mounjaro getting the broader clinical nod is well supported in the trials. The superiority claim has to be held with the caveat that some people find Ozempic works better for them specifically, but on average the tirz data is stronger.
 
The trial data does show tirzepatide outperforming on average but the individual variation is real - some people get better results with semaglutide, probably related to which receptor they're more sensitive to. For someone who's already responded well to one, the comparison is really about whether you've plateaued rather than which is theoretically better.
 
the non-responder pathway from semaglutide to tirzepatide or retatrutide is well-supported - the dual and triple agonist mechanisms address more receptor types, which produces meaningful additional response in people who didn't get sufficient effect from GLP-1 alone. the transition is worth discussing with a prescriber rather than just switching since the dose titration and side effect profile differ
 
You must log in or register to reply here.
Back
Top